Results 21 to 30 of about 3,531 (166)

Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]

BMC Nephrol
Background Atypical Hemolytic Uremic Syndrome (aHUS) is a life-threatening disease related to mutations in the complement system. We report the first known case of the use of factor B inhibition in a 21-year-old male with complement-mediated thrombotic ...
Nguyen MD, Ciurea S, Desai S, Kalebasty AR, Tran MH, Gee C, Tadros M, Nguyen VQ, Patel S, Selamet U, Hanna R.   +10 more
europepmc   +2 more sources

A rare cause of retroperitoneal mass: Castleman's disease

Apollo Medicine, 2018
Castleman's disease is a rare lymphoproliferative disorder. It is a pathological diagnosis and rarely diagnosed before surgery. Presentation of disease may be unicentric or multicentric.
Satyaprakash Jindal, G K Adithya, Varun Madaan, Rigved Gupta, Sandeep Vohra, Vivek Tandon, Deepak Govil   +6 more
doaj   +1 more source

Idiopathic multicentric Castleman’s disease: a clinicopathologic study in comparison with IgG4-related disease [PDF]

, 2018
The present study aimed to compare clinicopathologic features between idiopathic multicentric Castleman’s disease (n=22) and IgG4-related disease (n=26). Histology was analyzed using lymph node and lung biopsies. The expression of IL-6 mRNA in tissue was
Kyoko Otani, Fujikura, Kohei, Komori, Takahiro, Abe-Suzuki, Shiho, Dai Inoue, Yoh Zen, Takuma Tajiri, Otani, Kyoko, Tajiri, Takuma, Zen, Yoh, Takahiro Komori, Inoue, Dai, Shiho Abe-Suzuki, Tomoo Itoh, Kohei Fujikura, Itoh, Tomoo   +15 more
core   +1 more source

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature

BMC Nephrology, 2021
Background Multicentric Castleman’s disease is a life-threatening disorder involving a systemic inflammatory response and multiple organ failure caused by the overproduction of interleukin-6. Although renal complications of Castleman’s disease include AA
Ryosuke Saiki, Kan Katayama, Yosuke Hirabayashi, Keiko Oda, Mika Fujimoto, Tomohiro Murata, Ayako Nakajima, Kaoru Dohi   +7 more
doaj   +1 more source

Castleman’s Disease Presenting as an Abdominal Mass [PDF]

International Journal of Anatomy Radiology and Surgery, 2016
Castleman’s disease is an uncommon lymphoproliferative disorder. It can present as unicentric disease or multicentric disease. Here we present a case in which a 60 year old female who presented with upper abdominal discomfort was evaluated with ...
C. Valiathan Gopakumar, P.K. Reddy, J.K.A. Jameel   +2 more
doaj   +1 more source

Castleman’s disease of the bilateral parotid gland: a case report

B-ENT, 2006
Castleman’s disease of the bilateral parotid gland: a case report. Objective: Castleman’s disease (CD) is a benign lymphoproliferative disorder characterized by enlarged hyperplastic lymph nodes.
O. Akdogan, Y. Sarikaya, H. Dere, S. Bahar, Y. Firat   +4 more
doaj   +2 more sources

Primary mediastinal Castleman’s disease

, 2010
Castleman’s disease is a rare entity with an unknown etiology which was first described by Castleman in 1954. It is a lymphoproliferative disorder histologically classified into three types; hyaline-vascular, plasma cell type and mixed type.
Hanan Bousbait, Mohamed A. Regal, Yasser M. Aljehani   +2 more
core   +1 more source

Unicentric castleman's disease located in the lower extremity: a case report

BMC Cancer, 2011
Background Castleman's disease is a rare form of localized lymph node hyperplasia of uncertain etiology. Although the mediastinum is the most common site of involvement, rare cases occurring in lymph node bearing tissue of other localization have been ...
Schweyer Stefan, Günnel Harald, Schaefer Inga-Marie, Korenkov Michael   +3 more
doaj   +1 more source

Castleman’s Disease Mimetizing Pancreatic Tumor

, 2012
Context Angiofollicular lymph node hyperplasia or Castleman’s disease is a rare clinical condition. Knowledge about etiology and physiopathology; and treatment management as well are yet to be defined.
Beron, Reinaldo Isaacs, Goldman, Suzan Menasce, Apodaca-Torrez, Franz Robert, Filho, Benedito Herani, Goldenberg, Alberto, Lobo, Edson José   +5 more
core   +1 more source

Immunophenotypic characteristics of plasma cells in POEMS syndrome

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract To analyze the immunophenotypic characteristics of plasma cells in patients with polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes (POEMS) syndrome. This retrospective study included patients with POEMS syndrome hospitalized in the Department of Hematology, Huashan Hospital, from September 2017 to August 2025 ...
Zhenhua Wang, Tianling Ding, Beiqian Wu, Qiang Niu, Leyao Gu, Yan Yuan, Ping Zhu   +6 more
wiley   +1 more source